Results for tag: "Eye Neoplasm Drug"

The Eye Neoplasm Drug market is a subset of the Optical Disorders Drugs market, which focuses on the development and sale of drugs used to treat neoplasms of the eye. Neoplasms are abnormal growths of tissue that can occur in the eye, and can be benign or malignant. Eye neoplasm drugs are used to treat these growths, and can include chemotherapy, radiation therapy, and targeted therapy. These drugs are used to reduce the size of the neoplasm, reduce symptoms, and prevent the spread of the neoplasm. The Eye Neoplasm Drug market is highly competitive, with many companies offering a variety of drugs to treat eye neoplasms. Companies in the market include Novartis, Pfizer, Merck, Roche, and Allergan. Show Less Read more